Welwaze

Welwaze is committed to developing medical devices that enhance the level of care management. The company has developed Celbrea, a thermography software approved by the FDA for monitoring women's breast health based on angiogenesis. Its product, Celbrea TMD, can be used by physicians as an auxiliary tool during routine physical examinations, including palpation, mammography, and other established breast disease detection procedures.